» Articles » PMID: 40065235

The Relationship Between Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score and 28-day Mortality in Patients with Sepsis: a Retrospective Analysis of the MIMIC-IV Database

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2025 Mar 11
PMID 40065235
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In recent years, the hemoglobin, albumin, lymphocyte, and platelet (HALP) score has emerged as a potential marker of immunological and nutritional status. This study aimed to evaluate the association between the HALP score and prognosis in patients with sepsis.

Methods: This retrospective cohort study analyzed sepsis patients using clinical data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. Patients were classified into Low-score and High-score groups. Confounding factors were controlled through propensity score matching (PSM) analysis. The primary outcome was 28-day mortality in individuals with sepsis. Survival probabilities between groups were compared using Kaplan-Meier curves. Multivariable Cox regression analysis and a smoothing spline fitting curve were employed to investigate the relationship between the HALP score and 28-day mortality. ROC curve analysis and subgroup analysis were performed to evaluate the predictive ability of the HALP score and its components.

Results: A total of 2,968 sepsis patients were included, with 809 (27.26%) deaths within 28 days. After PSM analysis, the High-score group had a 24% lower risk of 28-day mortality compared to the Low-score group (HR, 0.76; 95% CI, 0.64-0.91). In the unmatched cohort, the multivariable Cox regression model also indicated that the High-score group had a lower 28-day mortality risk (HR, 0.78; 95% CI, 0.67-0.91). The smoothing spline fitting curve showed a nonlinear relationship between the HALP score and 28-day mortality, with an inflection point at 24.69. When the HALP score was below 24.69, an increase of one point in the HALP score was associated with a 2% reduction in 28-day mortality (HR, 0.98; 95% CI, 0.97-0.99). The HALP score provided incremental predictive value for 28-day mortality when combined with the SOFA score. Albumin was identified as the most influential component of the HALP score.

Conclusion: Among patients with sepsis, the HALP score exhibited a nonlinear relationship with 28-day mortality. An elevated HALP score is associated with reduced 28-day, 90-day, 360-day, and in-hospital mortality among sepsis patients.

References
1.
Gursoy V, Sadri S, Kucukelyas H, Hunutlu F, Pinar I, Yegen Z . HALP score as a novel prognostic factor for patients with myelodysplastic syndromes. Sci Rep. 2024; 14(1):13843. PMC: 11180126. DOI: 10.1038/s41598-024-64166-6. View

2.
Liu L, Gong B, Wang W, Xu K, Wang K, Song G . Association between haemoglobin, albumin, lymphocytes, and platelets and mortality in patients with heart failure. ESC Heart Fail. 2024; 11(2):1051-1060. PMC: 10966267. DOI: 10.1002/ehf2.14662. View

3.
Reinhart K, Daniels R, Kissoon N, Machado F, Schachter R, Finfer S . Recognizing Sepsis as a Global Health Priority - A WHO Resolution. N Engl J Med. 2017; 377(5):414-417. DOI: 10.1056/NEJMp1707170. View

4.
Yang J, Parkins M, Canakis A, Aroniadis O, Yadav D, Dixon R . Outcomes of COVID-19 Among Hospitalized Health Care Workers in North America. JAMA Netw Open. 2021; 4(1):e2035699. PMC: 7844592. DOI: 10.1001/jamanetworkopen.2020.35699. View

5.
Hu W, Chen H, Ma C, Sun Q, Yang M, Wang H . Identification of indications for albumin administration in septic patients with liver cirrhosis. Crit Care. 2023; 27(1):300. PMC: 10385943. DOI: 10.1186/s13054-023-04587-3. View